Media Coverage header image
 |
|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Screening and testing for sexually transmitted infections (STIs) fell dramatically - even as the share of positive tests increased - during the early months of the pandemic, a new study suggests. Researchers from Penn State University and Quest Diagnostics found that testing decreased by about 60 percent for both men and women.
The coronavirus pandemic shook up the U.S. employment picture last year, but one trend persisted: a rising share of workers who test positive for marijuana. The proportion of U.S. workers who tested positive for marijuana in urine climbed higher in 2020 while the overall share of positive drug tests plateaued last year, according to Quest Diagnostics Inc.
Quest Diagnostics is working with artificial-intelligence startup Paige to try to identify new biomarkers of cancer and other diseases and develop new software products, the companies said Tuesday. Quest and Paige plan to work together to develop software products that diagnose various cancers based on the biomarkers they discover, for which the companies will seek regulatory approval.
Childhood obesity has disproportionately affected Hispanic and Black communities as a result of negative social determinants of health for years. To help address the health inequity crisis, the Social and Health Research Center (SAHRC) of San Antonio, Texas has developed an evidenced-based program using an innovative digitized curriculum designed to engage children. Quest Diagnostics is collaborating with SAHRC to bring the curriculum to schools and communities where it is most needed.
The COVID-19 pandemic caused major decreases in hepatitis C virus testing and treatment, hindering efforts to meet WHO goals for 2030, according to a study in the American Journal of Preventive Medicine. “As much as we think about 2020 as the year of the pandemic, it’s also going to be the year that we're going to remember hepatitis C,” Harvey W. Kaufman, MD, senior medical director at Quest Diagnostics and head of Quest Diagnostics health trends research, told Healio.